Table 1.
Total (%) | All adherence 100% (%) | At least 1 adherence <100% (%) | |
---|---|---|---|
|
|
|
|
n=1316 (100) | n=890 (68) | n=426 (32) | |
Age, years | |||
≤30 | 321 (24) | 228 (26) | 93 (22) |
31–40 | 554 (42) | 352 (40) | 202 (47) |
41–50 | 316 (24) | 213 (24) | 103 (24) |
51+ | 125 (10) | 97 (11) | 28 (7) |
Sex | |||
Male | 879 (67) | 597 (67) | 282 (66) |
Female | 437 (33) | 293 (33) | 144 (34) |
HIV exposure category | |||
Heterosexual contact | 911 (69) | 601 (68) | 310 (73) |
Homosexual contact | 273 (21) | 211 (24) | 62 (15) |
Injecting drug use | 72 (5) | 33 (4) | 39 (9) |
Other or unknown | 60 (5) | 45 (5) | 15 (4) |
Pre-treatment CD4, cells/μL | |||
≤50 | 422 (32) | 291 (33) | 131 (31) |
51–100 | 200 (15) | 130 (15) | 70 (16) |
101–200 | 322 (24) | 204 (23) | 118 (28) |
201+ | 337 (26) | 240 (27) | 97 (23) |
Missing | 35 (3) | 25 (3) | 10 (2) |
Initial ART regimen | |||
NRTI+NNRTI | 1219 (93) | 807 (91) | 412 (97) |
NRTI+ PI | 76 (6) | 64 (7) | 12 (3) |
NRTI only | 21 (2) | 19 (2) | 2 (0) |
Hepatitis B co-infection | |||
Negative | 1030 (78) | 696 (78) | 334 (78) |
Positive | 128 (10) | 89 (10) | 39 (9) |
Not tested | 158 (12) | 105 (12) | 53 (12) |
Hepatitis C co-infection | |||
Negative | 950 (72) | 646 (73) | 304 (71) |
Positive | 90 (7) | 49 (6) | 41 (10) |
Not tested | 276 (21) | 195 (22) | 81 (19) |
Previous AIDS | |||
No | 826 (63) | 549 (62) | 277 (65) |
Yes | 490 (37) | 341 (38) | 149 (35) |